Niagen Bioscience, Inc. Common Stock NAGE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $66.55M+19.7% | $64.79M+45.1% | $64.29M+98.4% | $60.47M+117% | $55.62M+102% | ||
| $13.07M+85.3% | $9.74M+25.4% | $8.51M+19.9% | $9.66M+23.5% | $7.05M+6.8% | ||
| $24.02M+115% | $20.42M+122% | $18.79M+78.2% | $14.41M+25.1% | $11.19M-10.5% | ||
| $105.12M+37.9% | $96.81M+51.0% | $93.62M+79.6% | $86.68M+75.8% | $76.22M+55.6% | ||
| $1.3M-21.6% | $1.32M-23.0% | $1.5M-12.7% | $1.63M-11.4% | $1.66M-17.3% | ||
| $5.49M+1,603% | $5.66M+1,477% | $246K-38.0% | $284K-34.7% | $322K-31.8% | ||
| $114.33M+40.6% | $106.41M+55.8% | $98.14M+73.6% | $91.53M+69.4% | $81.34M+50.4% | ||
| $13.28M+24.9% | $10.8M+26.6% | $12.74M+84.6% | $13.68M+68.8% | $10.63M+34.6% | ||
| $380K+83.6% | $399K-34.7% | $292K+58.7% | $303K+94.2% | $207K-8.8% | ||
| $22.82M+9.5% | $19.92M+11.0% | $22.71M+28.3% | $22.33M+25.0% | $20.84M+7.1% | ||
| $32M+23.1% | $29.87M+34.7% | $27.46M+24.0% | $27.33M+17.2% | $25.99M+3.4% | ||
| 150M0.0% | 150M+194,705% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| -$158.21M+10.5% | -$164.53M+9.6% | -$168.66M+10.8% | -$173.24M+9.3% | -$176.85M+7.4% | ||
| $82.33M+48.8% | $76.53M+66.0% | $70.68M+106% | $64.2M+109% | $55.35M+91.2% | ||
| $114.33M+40.6% | $106.41M+55.8% | $98.14M+73.6% | $91.53M+69.4% | $81.34M+50.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Niagen Bioscience, Inc. Common Stock's total assets?
- Niagen Bioscience, Inc. Common Stock (NAGE) holds $114.3M in total assets, up 40.6% year over year.
- How much debt does Niagen Bioscience, Inc. Common Stock have?
- Niagen Bioscience, Inc. Common Stock carries $2.6M in total debt against $82.3M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Niagen Bioscience, Inc. Common Stock have?
- Niagen Bioscience, Inc. Common Stock holds $66.5M in cash and equivalents.
- Can Niagen Bioscience, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 4.61 — current assets exceed current liabilities.
- Where does Niagen Bioscience, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
